NCT04477538

Brief Summary

The objective of this proposal is to broadly assess patient physical functioning following breast reconstruction.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 7, 2020

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

July 14, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 20, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2021

Completed
Last Updated

June 5, 2024

Status Verified

June 1, 2024

Enrollment Period

1.3 years

First QC Date

July 14, 2020

Last Update Submit

June 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Compare the physical well-being Q-score derived from the BREAST-Q between the two groups

    The physical well-being module is one of the domains of the BREAST-Q that can be administered in isolation. Patients answer specific questions with answers that range from 1-4 to 1-5. Upon completion of this component of the survey, a physical well-being-specific numerical score is generated. This is then converted, based on previously published Rasch-modeling to generate a Q-score whose values range from 0-100. This same approach is used for all other domains of the BREAST-Q. Pre- versus postoperative Q-scores for physical well-being can be directly compared to study the impact of surgery on physical well-being. Similarly, the physical-well-being domain can be readministered to provide a longitudinal assessment of physical function over time.

    Completion of study (estimated to be 30 months)

Secondary Outcomes (3)

  • Satisfaction with outcome

    Completion of study (estimated to be 30 months)

  • Satisfaction with breasts

    Completion of study (estimated to be 30 months)

  • Upper extremity function as measured by PROMIS Upper Extremity Short Form 7a

    Completion of study (estimated to be 30 months)

Study Arms (2)

Participants with prepectoral reconstruction

-Participants will complete the post-mastectomy breast reconstruction physical well-being survey

Other: Post-mastectomy breast reconstruction physical well-being survey

Participants with postpectoral reconstruction

-Participants will complete the post-mastectomy breast reconstruction physical well-being survey

Other: Post-mastectomy breast reconstruction physical well-being survey

Interventions

-The survey will ascertain: function status (BREAST Q - Physical Well Being Module and PROMIS upper extremity function), former interaction with physical or occupational therapy, amount of narcotics taken weekly due to chest/neck/breast pain, amount of Tylenol or similar anti-inflammatories taken weekly due to chest/neck/breast pain, and amount of muscle relaxants taken weekly due to chest/neck/breast pain.

Participants with postpectoral reconstructionParticipants with prepectoral reconstruction

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants who undergone breast reconstruction surgery with plastic surgery faculty at the Washington University School of Medicine Division of Plastic and Reconstructive Surgery.

You may qualify if:

  • Female
  • At least 18 years of age
  • Had a mastectomy for breast cancer or cancer prevention any time between 01/01/2010 and 06/30/2021.
  • Has undergone breast reconstruction surgery with plastic surgery faculty at the Washington University School of Medicine Division of Plastic and Reconstructive Surgery.
  • Able to understand and willing to sign an IRB-approved written informed consent document.

You may not qualify if:

  • Known distant metastatic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Related Links

Study Officials

  • Terence Myckatyn, M.D.

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2020

First Posted

July 20, 2020

Study Start

July 7, 2020

Primary Completion

November 8, 2021

Study Completion

November 8, 2021

Last Updated

June 5, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations